Advertisement
Screener

DAVITA INC. (DVA) Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

DAVITA INC. Comprehensive Income

DAVITA INC. (DVA) reported Comprehensive Income of $293.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-04

  • DAVITA INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $293.81M, a 1.85% increase year-over-year.
  • DAVITA INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $233.35M, a 5.43% decline year-over-year.
  • DAVITA INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $227.59M, a 105.29% increase year-over-year.
  • DAVITA INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $172.01M, a 30.49% decline year-over-year.
  • DAVITA INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $934.82M, a 37.95% increase from fiscal 2024.
  • DAVITA INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $677.63M, a 4.38% decline from fiscal 2023.
  • DAVITA INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $708.64M, a 12.40% increase from fiscal 2022.
  • DAVITA INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $630.46M, a 30.36% decline from fiscal 2021.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2026-06-30$293.81M
10-Q · filed 2026-08-04
$527.16M
10-Q · filed 2026-08-04
$754.75M
derived: sum of 3 quarters · filed 2026-08-04
$926.76M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$233.35M
10-Q · filed 2026-05-05
$460.95M
derived: sum of 2 quarters · filed 2026-05-05
$632.96M
derived: sum of 3 quarters · filed 2026-05-05
$921.42M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$227.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$399.60M
derived: sum of 2 quarters · filed 2026-02-11
$688.07M
derived: sum of 3 quarters · filed 2026-08-04
$934.82M
10-K · filed 2026-02-11
2025-09-30$172.01M
10-Q · filed 2025-10-29
$460.48M
derived: sum of 2 quarters · filed 2026-08-04
$707.22M
10-Q · filed 2025-10-29
$818.09M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$288.47M
10-Q · filed 2026-08-04
$535.21M
10-Q · filed 2026-08-04
$646.08M
derived: sum of 3 quarters · filed 2026-08-04
$893.52M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$246.75M
10-Q · filed 2026-05-05
$357.61M
derived: sum of 2 quarters · filed 2026-05-05
$605.06M
derived: sum of 3 quarters · filed 2026-05-05
$732.76M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$110.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$358.31M
derived: sum of 2 quarters · filed 2026-02-11
$486.01M
derived: sum of 3 quarters · filed 2026-02-11
$677.63M
10-K · filed 2026-02-11
2024-09-30$247.44M
10-Q · filed 2025-10-29
$375.14M
derived: sum of 2 quarters · filed 2025-10-29
$566.76M
10-Q · filed 2025-10-29
$734.24M
derived: sum of 4 quarters · filed 2026-02-11
2024-06-30$127.70M
10-Q · filed 2025-08-05
$319.32M
10-Q · filed 2025-08-05
$486.80M
derived: sum of 3 quarters · filed 2026-02-11
$671.58M
derived: sum of 4 quarters · filed 2026-02-11
2024-03-31$191.62M
10-Q · filed 2025-05-12
$359.10M
derived: sum of 2 quarters · filed 2026-02-11
$543.88M
derived: sum of 3 quarters · filed 2026-02-11
$770.43M
derived: sum of 4 quarters · filed 2026-02-11
2023-12-31$167.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$352.26M
derived: sum of 2 quarters · filed 2026-02-11
$578.81M
derived: sum of 3 quarters · filed 2026-02-11
$708.64M
10-K · filed 2026-02-11
2023-09-30$184.79M
10-Q · filed 2024-10-29
$411.33M
derived: sum of 2 quarters · filed 2024-10-29
$541.16M
10-Q · filed 2024-10-29
$675.63M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$226.54M
10-Q · filed 2024-08-06
$356.37M
10-Q · filed 2024-08-06
$490.84M
derived: sum of 3 quarters · filed 2025-02-13
$572.45M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31$129.83M
10-Q · filed 2024-05-02
$264.30M
derived: sum of 2 quarters · filed 2025-02-13
$345.91M
derived: sum of 3 quarters · filed 2025-02-13
$493.79M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$134.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$216.08M
derived: sum of 2 quarters · filed 2025-02-13
$363.96M
derived: sum of 3 quarters · filed 2025-02-13
$630.46M
10-K · filed 2025-02-13
2022-09-30$81.61M
10-Q · filed 2023-11-07
$229.49M
derived: sum of 2 quarters · filed 2023-11-07
$495.99M
10-Q · filed 2023-11-07
$663.97M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30$147.88M
10-Q · filed 2023-08-03
$414.38M
10-Q · filed 2023-08-03
$582.36M
derived: sum of 3 quarters · filed 2024-02-14
$788.26M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31$266.50M
10-Q · filed 2023-05-08
$434.48M
derived: sum of 2 quarters · filed 2024-02-14
$640.38M
derived: sum of 3 quarters · filed 2024-02-14
$991.08M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31$167.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$373.88M
derived: sum of 2 quarters · filed 2024-02-14
$724.58M
derived: sum of 3 quarters · filed 2024-02-14
$905.36M
10-K · filed 2024-02-14
2021-09-30$205.90M
10-Q · filed 2022-10-31
$556.61M
derived: sum of 2 quarters · filed 2022-10-31
$737.38M
10-Q · filed 2022-10-31
$967.53M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$350.70M
10-Q · filed 2022-08-01
$531.48M
10-Q · filed 2022-08-01
$761.63M
derived: sum of 3 quarters · filed 2023-02-22
$932.88M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$180.77M
10-Q · filed 2022-05-05
$410.92M
derived: sum of 2 quarters · filed 2023-02-22
$582.17M
derived: sum of 3 quarters · filed 2023-02-22
$789.19M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$230.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$401.40M
derived: sum of 2 quarters · filed 2023-02-22
$608.42M
derived: sum of 3 quarters · filed 2023-02-22
$754.99M
10-K · filed 2023-02-22
2020-09-30$171.25M
10-Q · filed 2021-10-28
$378.27M
derived: sum of 2 quarters · filed 2021-10-28
$524.84M
10-Q · filed 2021-10-28
$799.81M
derived: sum of 4 quarters · filed 2022-02-11
2020-06-30$207.02M
10-Q · filed 2021-08-03
$353.59M
10-Q · filed 2021-08-03
$628.56M
derived: sum of 3 quarters · filed 2022-02-11
$727.84M
derived: sum of 4 quarters · filed 2022-02-11
2020-03-31$146.57M
10-Q · filed 2021-04-29
$421.54M
derived: sum of 2 quarters · filed 2022-02-11
$520.82M
derived: sum of 3 quarters · filed 2022-02-11
$808.31M
derived: sum of 4 quarters · filed 2022-02-11
2019-12-31$274.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11
$374.25M
derived: sum of 2 quarters · filed 2022-02-11
$661.75M
derived: sum of 3 quarters · filed 2022-02-11
$798.41M
10-K · filed 2022-02-11
2019-09-30$99.28M
10-Q · filed 2020-10-29
$386.77M
derived: sum of 2 quarters · filed 2020-10-29
$523.43M
10-Q · filed 2020-10-29
$367.84M
derived: sum of 4 quarters · filed 2021-02-12
2019-06-30$287.49M
10-Q · filed 2020-07-30
$424.15M
10-Q · filed 2020-07-30
$268.57M
derived: sum of 3 quarters · filed 2021-02-12
$124.59M
derived: sum of 4 quarters · filed 2021-02-12
2019-03-31$136.66M
10-Q · filed 2020-05-05
-$18.93M
derived: sum of 2 quarters · filed 2021-02-12
-$162.91M
derived: sum of 3 quarters · filed 2021-02-12
$55.11M
derived: sum of 4 quarters · filed 2021-02-12
2018-12-31-$155.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12
-$299.57M
derived: sum of 2 quarters · filed 2021-02-12
-$81.55M
derived: sum of 3 quarters · filed 2021-02-12
$119.60M
10-K · filed 2021-02-12
2018-09-30-$143.98M
10-Q · filed 2019-11-07
$74.04M
derived: sum of 2 quarters · filed 2019-11-07
$275.19M
10-Q · filed 2019-11-07
$588.35M
derived: sum of 4 quarters · filed 2020-02-21
2018-06-30$218.02M
10-Q · filed 2019-08-02
$419.17M
10-Q · filed 2019-08-02
$732.33M
derived: sum of 3 quarters · filed 2020-02-21
$548.63M
derived: sum of 4 quarters · filed 2020-02-21
2018-03-31$201.15M
10-Q · filed 2019-05-07
$514.31M
derived: sum of 2 quarters · filed 2020-02-21
$330.62M
derived: sum of 3 quarters · filed 2020-02-21
$507.20M
derived: sum of 4 quarters · filed 2020-02-21
2017-12-31$313.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21
$129.46M
derived: sum of 2 quarters · filed 2020-02-21
$306.04M
derived: sum of 3 quarters · filed 2020-02-21
$766.50M
10-K · filed 2020-02-21
2017-09-30-$183.69M
10-Q · filed 2018-11-07
-$7.11M
derived: sum of 2 quarters · filed 2018-11-07
$453.34M
10-Q · filed 2018-11-07
$573.65M
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30$176.58M
10-Q · filed 2018-08-01
$637.03M
10-Q · filed 2018-08-01
$757.34M
derived: sum of 3 quarters · filed 2019-02-22
$1.34B
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31$460.45M
10-Q · filed 2018-05-03
$580.76M
derived: sum of 2 quarters · filed 2019-02-22
$1.16B
derived: sum of 3 quarters · filed 2019-02-22
$1.21B
derived: sum of 4 quarters · filed 2019-02-22
2016-12-31$120.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$699.45M
derived: sum of 2 quarters · filed 2019-02-22
$746.31M
derived: sum of 3 quarters · filed 2019-02-22
$850.06M
10-K · filed 2019-02-22
2016-09-30$579.14M
10-Q · filed 2017-11-07
$626.00M
derived: sum of 2 quarters · filed 2017-11-07
$729.75M
10-Q · filed 2017-11-07
$718.26M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$46.86M
10-Q · filed 2017-08-01
$150.61M
10-Q · filed 2017-08-01
$139.12M
derived: sum of 3 quarters · filed 2018-02-23
$345.03M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31$103.75M
10-Q · filed 2017-05-02
$92.26M
derived: sum of 2 quarters · filed 2018-02-23
$298.17M
derived: sum of 3 quarters · filed 2018-02-23
$471.89M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31-$11.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$194.43M
derived: sum of 2 quarters · filed 2018-02-23
$368.15M
derived: sum of 3 quarters · filed 2018-02-23
$234.92M
10-K · filed 2018-02-23
2015-09-30$205.91M
10-Q · filed 2016-11-02
$379.64M
derived: sum of 2 quarters · filed 2016-11-02
$246.41M
10-Q · filed 2016-11-02
$441.04M
derived: sum of 4 quarters · filed 2017-02-24
2015-06-30$173.72M
10-Q · filed 2016-08-08
$40.50M
10-Q · filed 2016-08-08
$235.13M
derived: sum of 3 quarters · filed 2017-02-24
$406.96M
derived: sum of 4 quarters · filed 2017-02-24
2015-03-31-$133.22M
10-Q · filed 2016-05-04
$61.40M
derived: sum of 2 quarters · filed 2017-02-24
$233.23M
derived: sum of 3 quarters · filed 2017-02-24
$383.22M
derived: sum of 4 quarters · filed 2017-02-24
2014-12-31$194.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$366.46M
derived: sum of 2 quarters · filed 2017-02-24
$516.45M
derived: sum of 3 quarters · filed 2017-02-24
$700.74M
10-K · filed 2017-02-24
2014-09-30$171.83M
10-Q · filed 2015-11-05
$321.82M
derived: sum of 2 quarters · filed 2015-11-05
$506.12M
10-Q · filed 2015-11-05
$719.96M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$149.99M
10-Q · filed 2015-08-05
$334.28M
10-Q · filed 2015-08-05
$548.13M
derived: sum of 3 quarters · filed 2016-02-26
$683.88M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$184.29M
10-Q/A · filed 2015-05-08
$398.14M
derived: sum of 2 quarters · filed 2016-02-26
$533.89M
derived: sum of 3 quarters · filed 2016-02-26
$801.67M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$213.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$349.60M
derived: sum of 2 quarters · filed 2016-02-26
$617.38M
derived: sum of 3 quarters · filed 2016-02-26
$646.10M
10-K · filed 2016-02-26
2013-09-30$135.75M
10-Q · filed 2014-11-06
$403.53M
derived: sum of 2 quarters · filed 2014-11-06
$432.25M
10-Q · filed 2014-11-06
$591.08M
derived: sum of 4 quarters · filed 2015-02-26
2013-06-30$267.78M
10-Q · filed 2014-08-01
$296.50M
10-Q · filed 2014-08-01
$455.33M
derived: sum of 3 quarters · filed 2015-02-26
$601.15M
derived: sum of 4 quarters · filed 2015-02-26
2013-03-31$28.72M
10-Q · filed 2014-05-02
$187.54M
derived: sum of 2 quarters · filed 2015-02-26
$333.37M
derived: sum of 3 quarters · filed 2015-02-26
$428.09M
derived: sum of 4 quarters · filed 2015-02-26
2012-12-31$158.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26
$304.64M
derived: sum of 2 quarters · filed 2015-02-26
$399.37M
derived: sum of 3 quarters · filed 2015-02-26
$540.20M
10-K · filed 2015-02-26
2012-09-30$145.82M
10-Q · filed 2013-11-06
$240.55M
derived: sum of 2 quarters · filed 2013-11-06
$381.38M
10-Q · filed 2013-11-06
$530.87M
derived: sum of 4 quarters · filed 2014-02-21
2012-06-30$94.73M
10-Q · filed 2013-08-07
$235.56M
10-Q · filed 2013-08-07
$385.05M
derived: sum of 3 quarters · filed 2014-02-21
$511.35M
derived: sum of 4 quarters · filed 2014-02-21
2012-03-31$140.83M
10-Q · filed 2013-05-09
$290.33M
derived: sum of 2 quarters · filed 2014-02-21
$416.62M
derived: sum of 3 quarters · filed 2014-02-21
$506.52M
derived: sum of 4 quarters · filed 2014-02-21
2011-12-31$149.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21
$275.79M
derived: sum of 2 quarters · filed 2014-02-21
$365.69M
derived: sum of 3 quarters · filed 2014-02-21
$458.01M
10-K · filed 2014-02-21
2011-09-30$126.29M
10-Q · filed 2012-10-31
$216.20M
derived: sum of 2 quarters · filed 2012-10-31
$308.52M
10-Q · filed 2012-10-31
2011-06-30$89.91M
10-Q · filed 2012-08-03
$182.23M
10-Q · filed 2012-08-03
2011-03-31$92.32M
10-Q · filed 2012-05-02
2010-12-31$411.73M
10-K · filed 2013-03-01
2009-12-31$431.48M
8-K · filed 2012-07-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sotera Health Co (SHC)United States$5.271B30.96
Progyny, Inc. (PGNY)United States$1.994B28.37
agilon health, inc. (AGL)United States$1.272B-7.76
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43